In This Issue

Radionuclides, or radioactive forms of an element, represent a promising therapy for metastatic cancer, as their ionizing radiation can effectively target, kill cancer cells, and limit damage to nearby tissues.Consequently, liposome-encapsulated radionuclides have garnered significant attention, as liposomes' lipid bilayer protects radionuclides and prolongs their circulation time, while their surface can be modified with antibodies for targeted delivery.